Literature DB >> 34516249

Species-Specific Differences in C-5 Sterol Desaturase Function Influence the Outcome of Azole Antifungal Exposure.

Arturo Luna-Tapia1, Josie E Parker2, Steven L Kelly2, Glen E Palmer3.   

Abstract

The azole antifungals inhibit sterol 14α-demethylase (S14DM), leading to depletion of cellular ergosterol and the synthesis of an aberrant sterol diol that disrupts membrane function. In Candida albicans, sterol diol production is catalyzed by the C-5 sterol desaturase enzyme encoded by ERG3. Accordingly, mutations that inactivate ERG3 enable the fungus to grow in the presence of the azoles. The purpose of this study was to compare the propensities of C-5 sterol desaturases from different fungal pathogens to produce the toxic diol upon S14DM inhibition and thus contribute to antifungal efficacy. The coding sequences of ERG3 homologs from C. albicans (CaERG3), Candida glabrata (CgERG3), Candida auris (CaurERG3), Cryptococcus neoformans (CnERG3), Aspergillus fumigatus (AfERG3A-C) and Rhizopus delemar (RdERG3A/B) were expressed in a C. albicans erg3Δ/Δ mutant to facilitate comparative analysis. All but one of the Erg3p-like proteins (AfErg3C) at least partially restored C-5 sterol desaturase activity and to corresponding degrees rescued the stress and hyphal growth defects of the C. albicans erg3Δ/Δ mutant, confirming functional equivalence. Each C-5 desaturase enzyme conferred markedly different responses to fluconazole exposure in terms of the MIC and residual growth observed at supra-MICs. Upon fluconazole-mediated inhibition of S14DM, the strains expressing each homolog also produced various levels of 14α-methylergosta-8,24(28)-dien-3β,6α-diol. The RdErg3A and AfErg3A proteins are notable for low levels of sterol diol production and failing to confer appreciable azole sensitivity upon the C. albicans erg3Δ/Δ mutant. These findings suggest that species-specific properties of C-5 sterol desaturase may be an important determinant of intrinsic azole sensitivity.

Entities:  

Keywords:  C-5 desaturase; Candida; ERG3; antifungal; azole; ergosterol; resistance; tolerance

Mesh:

Substances:

Year:  2021        PMID: 34516249      PMCID: PMC8597749          DOI: 10.1128/AAC.01044-21

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  38 in total

1.  Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients.

Authors:  S Perea; J L López-Ribot; W R Kirkpatrick; R K McAtee; R A Santillán; M Martínez; D Calabrese; D Sanglard; T F Patterson
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

2.  The G464S amino acid substitution in Candida albicans sterol 14alpha-demethylase causes fluconazole resistance in the clinic through reduced affinity.

Authors:  S L Kelly; D C Lamb; J Loeffler; H Einsele; D E Kelly
Journal:  Biochem Biophys Res Commun       Date:  1999-08-19       Impact factor: 3.575

3.  Loss of C-5 Sterol Desaturase Activity in Candida albicans: Azole Resistance or Merely Trailing Growth?

Authors:  Arturo Luna-Tapia; Arielle Butts; Glen E Palmer
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

4.  The R467K amino acid substitution in Candida albicans sterol 14alpha-demethylase causes drug resistance through reduced affinity.

Authors:  D C Lamb; D E Kelly; T C White; S L Kelly
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

5.  Azole resistance by loss of function of the sterol Δ⁵,⁶-desaturase gene (ERG3) in Candida albicans does not necessarily decrease virulence.

Authors:  L A Vale-Silva; A T Coste; F Ischer; J E Parker; S L Kelly; E Pinto; D Sanglard
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.191

6.  The physiological roles of membrane ergosterol as revealed by the phenotypes of syr1/erg3 null mutant of Saccharomyces cerevisiae.

Authors:  K Hemmi; C Julmanop; D Hirata; E Tsuchiya; J Y Takemoto; T Miyakawa
Journal:  Biosci Biotechnol Biochem       Date:  1995-03       Impact factor: 2.043

7.  Deletion of the Candida glabrata ERG3 and ERG11 genes: effect on cell viability, cell growth, sterol composition, and antifungal susceptibility.

Authors:  A Geber; C A Hitchcock; J E Swartz; F S Pullen; K E Marsden; K J Kwon-Chung; J E Bennett
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

8.  Fluconazole modulates membrane rigidity, heterogeneity, and water penetration into the plasma membrane in Saccharomyces cerevisiae.

Authors:  Fumiyoshi Abe; Keiko Usui; Toshiki Hiraki
Journal:  Biochemistry       Date:  2009-09-15       Impact factor: 3.162

9.  Implications of the EUCAST Trailing Phenomenon in Candida tropicalis for the In Vivo Susceptibility in Invertebrate and Murine Models.

Authors:  K M T Astvad; D Sanglard; E Delarze; R K Hare; M C Arendrup
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

Review 10.  Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond.

Authors:  Yunjin Lee; Emily Puumala; Nicole Robbins; Leah E Cowen
Journal:  Chem Rev       Date:  2020-05-22       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.